This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations in Gene Therapy: The Contributions of Gary S. Hayward
Introduction: Gary S. Hayward, an accomplished inventor based in Towson, Maryland, has made significant contributions to the field of gene therapy through his innovative research and patented methods. His work focuses on the large-scale production of recombinant Adeno-Associated Virus (AAV) vectors, which are essential for advancing gene therapy applications.
Latest Patents: Gary S. Hayward holds a patent for "Methods for large-scale production of recombinant AAV vectors." This patent discloses HSV-1 amplicons that provide essential helper functions for rAAV packaging. The innovation includes methods capable of rescuing and replicating all forms of rAAV genomes, such as those introduced into cells by infection of rAAV virions, transfected plasmids, or integrated proviral rAAV genomes within cellular chromosomal DNA. Additionally, the patent outlines methods for creating high-titer rAAV vector compositions, which are crucial for effective gene therapy and the targeted delivery of exogenous polynucleotides to specific host cells.
Career Highlights: Gary is affiliated with the University of Florida Research Foundation, Incorporated, where he advances research in biotechnology and gene therapy. His single patent underscores his expertise and contribution to the field, showcasing his innovative spirit and dedication to improving therapeutic techniques.
Collaborations: Throughout his career, Gary has worked alongside esteemed colleagues such as Barry John Byrne and James E. Conway. These collaborations have facilitated knowledge exchange and enhanced the development of technologies pertaining to gene therapy.
Conclusion: Through his groundbreaking patent and collaborative efforts, Gary S. Hayward has established himself as a notable inventor in the biotechnology sector. His work in developing methods for the production of recombinant AAV vectors is expected to continue influencing the future of gene therapy and medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile